Objective: To explore the feasibility of radical resection for cancer patients complicated with coronavirus disease 2019 (COVID-19).
Methods: The management and clinical outcome of a sigmoid cancer patient with COVID-19 were analyzed.
Results: The inflammation indicators and fever of this patient were effectively controlled and the lung lesions remained stable after active anti-viral treatment, then the radical colorectomy was performed after the viral negative conversion for twice.
Conclusions: The case indicates that radical resection can be performed in SARS-CoV-2 patients with twice-negative SARS-CoV-2 nucleic acid testing results.
目的: 探讨亟待进行肿瘤根治术的患者合并2019冠状病毒病（COVID-19）后如何选择手术治疗时机。
方法: 详细分析1例乙状结肠癌合并COVID-19患者的治疗过程，以及该患者在病毒两次转阴后进行根治性手术后的恢复情况。
结果: 患者术后恢复良好，炎症指标、发热等临床表现改善，肺部病灶也维持稳定。
结论: 对于亟待进行肿瘤根治术且合并COVID-19的患者，在符合病毒核酸检测两次阴性之后进行肿瘤根治术是可行的。